(Press-News.org) New technologies allow users to do things like race their real bikes against other real people in a virtual world, and a new study outlines what motivates people to use these online platforms. The findings offer insights for future iterations of these technologies - and how to market them.
At issue are "mixed-reality sports": augmented reality platforms that incorporate virtual, online elements and real-world athletic endeavors. For example, Zwift is a platform that allows users to ride their real bicycles, but transfers their efforts to a virtual space depicting real-world courses - allowing them to race against other cyclists who are not physically present.
"We know that mixed-reality sports are attracting a lot of users," says Bill Rand, co-author of the paper and an associate professor of marketing in North Carolina State University's Poole College of Management. "We want to know what benefits people see in these technologies. What about risks? And how do those risks and benefits affect their actual use?
"This matters because once we understand why people are using, or not using, these technologies, we can figure out how to make the technologies for appealing for users - and also how to market them more effectively."
For this study, the researchers conducted a survey of 284 Zwift users in Germany, Austria and Switzerland. The survey collected data on each study participant's background, their motivations for using Zwift, any concerns they had about the platform, and the extent to which they felt they would continue using Zwift in the future. The researchers were then able to review each study participant's use of Zwift for 30 days after taking the survey. The study design allowed the researchers to identify any relationships between a study participant's motivations, perceived risks, their expectations for using Zwift, and their actual use of Zwift.
One of the things researchers found surprising was that users were simply not motivated by competing against other users within the game environment itself.
"The Zwift platform is designed specifically to enable competition, either informally amongst friends, or in formal races involving many competitors," Rand says. "However, we found that even the people who take part in the formal races are not strongly motivated by these in-game contests."
Instead, researchers found that four other drivers were associated with Zwift use: health consciousness; using Zwift to train for real-world competitions; socializing with others; and the ability to customize and upgrade their gaming experience by modifying their jerseys, "earning" access to new bike styles, and so on.
"To provide a more profound explanation of the quantitative results, we also conducted 14 interviews with platform users," says Daniel Westmattelmann, corresponding author of the paper, an assistant professor of sports management at the University of Münster and a former professional cyclist. "It was fascinating to see that even elite athletes who have won Tour de France stages, for example, are strongly motivated to use the platform more intensively because of customizing or socializing elements."
The researchers also found that study participants who had privacy concerns about Zwift engaged with the platform less frequently.
"There are a variety of these mixed-reality sports platforms out there, such as Peloton, with varying ratios of virtual elements to real-world elements," Rand says. "And this field is likely to grow. Our work gives us insight into what may be motivating participants on these platforms.
"For example, the ability to customize your avatar appears to be important. Social interaction and online communities are important. Health and fitness are important. Privacy concerns are important.
"Understanding the things that are important to users can help developers of next-generation mixed-reality sports technologies design more appealing products," Rand says. "And can help marketers determine which aspects of these products to highlight for consumers."
The paper, "Apart we ride together: The motivations behind users of mixed-reality sports," appears in the Journal of Business Research. The paper was co-authored by Jan-Gerrit Grotenhermen, Marius Sprenger and Gerhard Schewe of the University of Münster.
INFORMATION:
Medical guidelines help doctors understand the best way to treat health conditions. Surprisingly, many doctors do not adhere to them, and this is a problem, according to a new study by scientists at University of Utah Health and MDGuidelines. People with lower back pain injury miss 11 more days of work in a year when they only receive treatments for lower back pain that are not recommended by medical guidelines compared to people treated according to guidelines. The findings publish in END ...
Light-driven molecular motors have been around for over twenty years. These motors typically take microseconds to nanoseconds for one revolution. Thomas Jansen, associate professor of physics at the University of Groningen, and Master's student Atreya Majumdar have now designed an even faster molecular motor. The new design is driven by light only and can make a full turn in picoseconds, using the power of a single photon. Jansen: 'We have developed a new out-of-the-box design for a motor molecule that is much faster.' The design was published in The Journal of Physical Chemistry ...
When astronomers using NASA's Hubble Space Telescope uncovered an oddball galaxy that looked like it didn't have much dark matter, some thought the finding was hard to believe and looked for a simpler explanation.
Dark matter, after all, is the invisible glue that makes up the bulk of the universe's matter. All galaxies appear to be dominated by it; in fact, galaxies are thought to form inside immense halos of dark matter.
So, finding a galaxy lacking the invisible stuff is an extraordinary claim that challenges conventional wisdom. It would have the potential to upset theories of galaxy formation and evolution.
To bolster their original finding, first reported in 2018 ...
The intestinal disease necrotizing enterocolitis is a leading cause of death among premature infants born in the U.S. and across the globe. Characterized by excessive inflammation that can cause tissue decay in the bowels, the disease provides a pathway for infectious and deadly bacteria to enter the bloodstream.
Despite four decades of research, effective treatments remain elusive, and mortality rates in babies who develop the disease have remained essentially unchanged, hovering at about 30%.
Now, a study led by researchers at Washington University ...
Personalised coaching through a smartphone platform can help women improve their lifestyle behaviours in the period before and shortly after they become pregnant, a new study has shown. The biggest reduction in behaviours that pose risks to pregnancy were seen in overweight women.
The findings, published in the journal Reproductive Biomedicine Online, show that digital healthcare could be a cost-effective way to deliver tailored advice to women who experience difficulties in pregnancy, which the NHS does not have the resources to provide.
In this study, led by the University of Southampton, 262 women who were planning pregnancies and had either experienced difficulties in conceiving or recurrent miscarriages signed ...
June 17, 2021 - Nutley, NJ - Tiny genetic markers, circulating in the blood, have shown great promise in diagnosing and treating disease. Yet identifying and harvesting these extracellular vesicles (EVs) have been a major challenge for science.
Now a laboratory at the Hackensack Meridian Center for Discovery and Innovation (CDI) has discovered a highly sensitive methodology that can efficiently find and harness EVs - particularly exosomes and the micro RNAs they carry. These could be crucial clues to identifying diseases such as cancer early on in its development.
The scientists have now unveiled the Extracellular Vesicle Capture by AnTibody of CHoice and 1 Enzymatic Release, or EV-CATCHER, in the Journal of Extracellular Vesicles.
"We are establishing the threshold ...
TAMPA, Fla. (June 17, 2021) - Tests that analyze biomarkers are used during cancer management to guide treatment and provide information about patient prognosis. These tests are often performed on tissue biopsy samples that require invasive procedures and can lead to significant side effects. In a new article published in the Journal for ImmunoTherapy of Cancer, Moffitt Cancer Center researchers show that PET/CT images can be used to measure levels of the PD-L1 biomarker of non-small cell lung cancer (NSCLC) patients in a non-invasive manner and, in turn, predict a patient's response to therapy. ...
As pandemic restrictions begin to loosen around the country and summer temperatures rise, more people will be moving about on public rideshare electric scooters. With that comes this warning: Ride with safety.
A Henry Ford Health System study published in The Laryngoscope, shows that head and neck injuries caused by use of e-scooters have been on the rise since rideshare systems were introduced to the public in late 2017.
Kathleen Yaremchuk, M.D., Chair of the Department of Otolaryngology - Head and Neck Surgery and the study's senior author, said that a review of emergency visits in the last three years showed e-scooter injuries have increased significantly with many related to head and neck injuries. "Since e-scooters became a popular form of ...
In the Name of Racial Justice: Why Bioethics Should Care about Environmental Toxins
Keisha Ray
Facilities that emit hazardous toxins, such as toxic landfills, oil refineries, and chemical plants, are disproportionately located in predominantly Black, Latinx, and Indigenous neighborhoods. Environmental injustices like these threaten just distribution of health itself. Facilities that emit environmental toxins wrongly make people's race, ethnicity, income, and neighborhood essential to who is allowed to breathe clean air and drink clean water, and thus, who is allowed to be healthy. This ...
A large, retrospective, multicenter study involving Washington University School of Medicine in St. Louis indicates that convalescent plasma from recovered COVID-19 patients can dramatically improve likelihood of survival among blood cancer patients hospitalized with the virus.
The therapy involves transfusing plasma -- the pale yellow liquid in blood that is rich in antibodies -- from people who have recovered from COVID-19 into patients who have leukemia, lymphoma or other blood cancers and are hospitalized with the viral infection. The goal is to accelerate their disease-fighting response. Cancer patients may be at a higher risk of death related to COVID-19 because of their weakened immune systems.
The data, collected as part ...
